The U.S. Food and Drug Administration has just given the green light to a promising monoclonal antibody therapy co-developed by Canadian scientists to treat mild to moderate coronavirus infections — a groundbreaking product that's still hasn't been approved by Health Canada for use in this country.
https://ift.tt/2ItiIjK
0 التعليقات:
إرسال تعليق